Senna
Important Disclaimer
This is not medical advice. Consult a qualified healthcare provider before using any remedy, especially if pregnant, breastfeeding, on medication, or managing a health condition.
Overview
Senna alexandrina is a leguminous shrub native to tropical and subtropical Africa and Asia, best known as one of the world's most effective and widely used natural laxatives. The dried leaves and pods contain sennosides A and B — anthraquinone glycoside compounds that are metabolized by colonic bacteria into rhein anthrone, which stimulates colonic peristalsis and increases fluid secretion, producing reliable bowel movements within 6–12 hours. Senna has been used medicinally for over 1,000 years in Islamic, Ayurvedic, and African traditional medicine, and today its sennosides are the active ingredients in numerous over-the-counter pharmaceutical laxative products worldwide (including Senokot, X-Prep, and generic preparations). Crucially, the FDA has approved senna as a Category I safe and effective OTC laxative — one of the only plants to achieve this regulatory status.
Traditional Use
Senna's documented medicinal use begins with Islamic Golden Age physicians of the 9th–12th centuries CE. The Arab physician Ibn Massawaih (d. 857 CE) is credited with introducing senna to medicine, and it was subsequently described and recommended by all major Islamic physicians including Ibn Sina (Avicenna, d. 1037), who devoted a full chapter to senna in his Canon of Medicine. Avicenna described senna as the best laxative known — safe, reliable, and effective — and recommended it for constipation, melancholy, and skin conditions. Medieval European physicians adopted senna through Arabic medical texts. By the 13th–14th centuries, senna was being imported to Europe from Africa and the Middle East in substantial quantities, and became one of the most important items in the medieval European apothecary. It appears in the works of all major European herbalists of the period. In Ayurvedic medicine, senna (called Svarna-patra or Markandika) is described in later classical texts as an effective purgative for treating constipation, fever, abdominal disorders, and skin diseases. It is categorized as a drug that purges pitta and kapha doshas. In traditional Islamic medicine (Tibb-e-Nabawi), senna was reportedly recommended by the Prophet Muhammad as a medicinal plant, giving it particular cultural and religious significance in Muslim communities worldwide. Senna tea is still commonly used in Saudi Arabia, Egypt, and other Muslim-majority countries as a traditional remedy and religious practice. In East African traditional medicine, including in its native habitats of Sudan and Somalia, senna leaves and pods have been used for generations as a primary treatment for constipation. In Chinese traditional medicine, fan xie ye (senna leaves) were introduced via the Silk Road trade and incorporated into Chinese pharmacopoeia for purgative applications. Commercial production of senna for pharmaceutical use is centered in India (Tamil Nadu — the source of Tinnevelly senna) and Sudan (Alexandrian senna), with India being the world's largest producer and exporter.
Key Active Compounds
Sennoside A and B (Dianthrone Anthraquinone Glycosides)
The primary active compounds — these are prodrugs that pass through the small intestine largely unchanged and are metabolized by gut bacteria in the colon into rhein anthrone, the active laxative metabolite. Rhein anthrone stimulates colonic peristalsis (propulsive contractions) and increases chloride secretion into the colon, preventing water absorption and producing soft, hydrated stools. The 6–12 hour onset is due to the time required for intestinal transit and bacterial metabolism.
Sennoside C and D (Minor Anthraquinone Glycosides)
Minor anthraquinone compounds with similar but less potent laxative activity, contributing to the overall efficacy of whole senna preparations. The complete anthraquinone profile of senna leaf is more effective and better tolerated than isolated sennosides.
Kaempferol and Its Glycosides (Kaempferin, Isomucronulatol)
Significant flavonoid content contributing anti-inflammatory and antioxidant activity. These flavonoids also contribute to the mild intestinal anti-inflammatory effects observed with senna use and may modulate the intensity of the laxative effect.
Mucilage and Polysaccharides
The seed pods are particularly rich in mucilaginous polysaccharides that coat the intestinal lining, protecting it from irritation and contributing to the demulcent properties. This protective mucilage may explain the better tolerability of whole plant preparations versus concentrated sennoside extracts.
Evidence-Based Benefits
Constipation Relief
Strong evidenceThe primary and most evidence-based indication. FDA Category I designation confirms senna as safe and effective for occasional constipation. Multiple clinical trials confirm reliable bowel movement induction within 6–12 hours. Particularly effective for: pre-procedure bowel preparation (colonoscopy), opioid-induced constipation (in palliative care), postoperative constipation, and chronic constipation in elderly patients. Systematic reviews confirm senna's superiority to placebo and comparable efficacy to synthetic laxatives.
Pre-procedure Bowel Preparation
Strong evidenceSenna is one of the most commonly used agents for colonoscopy bowel preparation. Multiple clinical trials compare senna favorably with polyethylene glycol (PEG) preparations for bowel cleansing. Senna-based protocols are used routinely in many hospitals due to effectiveness, low cost, and better patient tolerance compared to high-volume PEG preparations.
Opioid-Induced Constipation (Palliative Care)
Strong evidenceSenna is a guideline-recommended first-line laxative for opioid-induced constipation in palliative and cancer care settings. Multiple clinical guidelines (including WHO palliative care guidelines) specify senna as the preferred stimulant laxative for this indication. The stimulant mechanism is particularly important in opioid-induced constipation where gut motility is severely impaired.
Skin Conditions (Traditional)
Traditional useTraditional Islamic, Ayurvedic, and African use of senna for skin conditions (acne, eczema, psoriasis) — based on the traditional concept that constipation and intestinal toxins contribute to skin problems. Modern research on gut-skin axis provides some mechanistic support for this traditional use. Anthraquinones may have direct antimicrobial activity on skin pathogens.
Common Preparation Methods
Standardized Preparation — Tablet/Capsule (Recommended)
Use pharmaceutical-grade standardized senna tablets or capsules standardizing sennoside content (typically 15–30mg sennosides per tablet, e.g., Senokot, Ex-Lax, or generic equivalents).
Dosage: Adults: 15–30mg sennosides (typically 2 tablets at bedtime). Maximum: 30mg sennosides per day. Expect bowel movement 6–12 hours after taking.This is the most reliable, well-studied, and regulated form. The standardized sennoside content ensures consistent dosing. Take at bedtime for morning bowel movement. Use the minimum effective dose. Drink adequate water (at least 250ml) with each dose. NOT for daily long-term use — see safety notes.
Senna Tea (Traditional)
Steep 1–2g of dried senna leaves in 1 cup of hot (not boiling) water for 10 minutes. Strain thoroughly. Drink in the evening.
Dosage: 1 cup in the evening; allow 8–12 hours for effectTraditional preparation. Less reliably dosed than standardized tablets. The mild, slightly bitter tea can be improved by adding peppermint or ginger. Strain carefully — the mucilage from pods can be gritty. Pods (half a pod per cup) are considered somewhat milder than leaves. Avoid using senna tea daily for more than 1 week.
Senna Pods (Gentler Traditional Form)
Steep 2–4 Senna pods (not leaves) in 1 cup of hot water for 10 minutes.
Dosage: 1 cup in the eveningThe pods are traditionally considered milder and better tolerated than the leaves, with less cramping. Traditional Islamic medicine preference. Lower sennoside content but with more protective mucilage. Good for those sensitive to cramping with leaf preparations. Often combined with fennel or peppermint to reduce griping.
Safety & Cautions
Please read carefully before use
Contraindications
- Intestinal obstruction — ABSOLUTELY CONTRAINDICATED; senna is dangerous if bowel is obstructed
- Appendicitis or acute abdominal conditions — do not use without medical evaluation
- Inflammatory bowel disease (Crohn's, colitis) — avoid stimulant laxatives
- Pregnancy — stimulant laxatives are generally avoided; consult physician
- Children under 12 — only under medical supervision
- Chronic kidney disease — long-term use and electrolyte loss is a concern
Drug Interactions
- Cardiac glycosides (digoxin) — hypokalemia from senna use can increase digoxin toxicity; SERIOUS interaction
- Antiarrhythmic drugs — electrolyte imbalances from chronic use may destabilize
- Diuretics — additive electrolyte loss (particularly potassium); MONITOR
- Corticosteroids — additive potassium depletion
- Estrogen — may affect absorption; take separately
Possible Side Effects
- Common: abdominal cramping (griping) — minimize with adequate water and starting with lower doses
- Common: temporary discoloration of urine (harmless — anthraquinone metabolites)
- Long-term daily use: AVOID — can cause dependency (lazy bowel), electrolyte imbalances (especially hypokalemia), and melanosis coli (harmless dark pigmentation of colon wall)
- Chronic overuse: hypokalemia with muscle weakness, cardiac arrhythmias
- Rare: hepatotoxicity reported with chronic excessive use (case reports only)
Special Populations
- Use only for short-term, occasional constipation — maximum 1–2 weeks continuous use
- Elderly: effective and commonly used, but start with lowest dose and monitor for electrolyte imbalance
- Pregnancy: avoid in first trimester; use only under obstetric guidance if absolutely necessary
- Breastfeeding: limited excretion into breast milk; short-term use considered acceptable by most authorities
- Children under 12: only under medical supervision at age-appropriate doses
- NEVER use for more than 2 weeks without medical supervision
Sources & References
U.S. Food and Drug Administration
Alimentary Pharmacology and Therapeutics
European Medicines Agency (EMA/HMPC)
Quick Reference
Fabaceae
Dried leaves, Dried seed pods (fruits), Standardized sennoside extract
Bitter, slightly sweet, mucilaginous; the tea has a mild, slightly unpleasant flavor; leaves are less bitter than pods; pods have a sweet-bitter profile
Safety First
Always consult with a qualified healthcare provider before starting any new remedy, especially if you have existing health conditions or take medications.